Stocks & Financial News
Breaking financial news 24/7 courtesy of TradingCharts.com Inc. / TFC Commodity Charts
Precision Trading with Moderna Inc. (MRNA) Risk Zones
Key findings for Moderna Inc. (NASDAQ: MRNA)
- Strong Sentiment Across All Horizons Supports Overweight Bias
- No clear price positioning signal identified.
- No resistance levels remain above current price -- compelling upside potential.
- Signals: 76.74 -- 111.56 -- 150.97 -- 200.61(bold = current price)
- Strong Sentiment Across All Horizons Supports Overweight Bias -- See current SIGNALS for positioning and risk parameters.
Institutional Trading Strategies
Our AI models have generated three distinct trading strategies tailored to different risk profiles and holding periods. Each strategy incorporates sophisticated risk management parameters designed to optimize position sizing and minimize drawdown risk.
Multi-Timeframe Signal Analysis
| Time Horizon | Signal Strength | Support Signal | Resistance Signal |
|---|---|---|---|
| Near-term (1-5 days) | Strong | $196.26 | $203.64 |
| Mid-term (5-20 days) | Strong | $193.43 | $208.37 |
| Long-term (20+ days) | Strong | $111.56 | $150.97 |
Technical Analysis
Longer Term Trading Plans for MRNA
- Buy MRNA near 150.97 target n/a stop loss @ 150.53. Details
- NONE . Details
The technical summary data tells us to buy MRNA near 150.97, but there is no current upside target from the summary table. In this case we should wait until either an update to the summary table has been made (which usually happens at the beginning of every trading day), or until the position has been stopped. The data does tell us to set a stop loss 150.53 to protect against excessive loss in case the stock begins to move against the trade. 150.97 is the first level of support below 200.61, and by rule, any test of support is a buy signal. In this case, if support 150.97 is being tested, a buy signal would exist.
NONE .
There are no current resistance levels from the summary table, and therefore there are no Short resistance Plans which tell us to short upon tests of resistance. Resistance levels have broken higher and unless the stock reverses lower and below support levels again short positions look risky.
Swing Trading Plans for MRNA
- Buy MRNA slightly over 208.37, target n/a, Stop Loss @ 207.77 Details
- Short MRNA slightly near 208.37, target 193.43, Stop Loss @ 208.97. Details
If 208.37 begins to break higher, the technical summary data tells us to buy MRNA just over 208.37, with an upside target of n/a. The data also tells us to set a stop loss @ 207.77 in case the stock turns against the trade. 208.37 is the first level of resistance above 200.61, and by rule, any break above resistance is a buy signal. In this case, 208.37, initial resistance, would be breaking higher, so a buy signal would exist. Because this plan is based on a break of resistance, it is referred to as a Long Resistance Plan.
The technical summary data is suggesting a short of MRNA if it tests 208.37 with a downside target of 193.43. We should have a stop loss in place at 208.97 though in case the stock begins to move against the trade. By rule, any test of resistance is a short signal. In this case, if resistance, 208.37, is being tested a short signal would exist. Because this plan is a short plan based on a test of resistance it is referred to as a Short Resistance Plan.
Day Trading Plans for MRNA
- Buy MRNA slightly over 203.64, target 208.37, Stop Loss @ 203.16 Details
- Short MRNA slightly near 203.64, target 196.26, Stop Loss @ 204.12. Details
If 203.64 begins to break higher, the technical summary data tells us to buy MRNA just over 203.64, with an upside target of 208.37. The data also tells us to set a stop loss @ 203.16 in case the stock turns against the trade. 203.64 is the first level of resistance above 200.61, and by rule, any break above resistance is a buy signal. In this case, 203.64, initial resistance, would be breaking higher, so a buy signal would exist. Because this plan is based on a break of resistance, it is referred to as a Long Resistance Plan.
The technical summary data is suggesting a short of MRNA if it tests 203.64 with a downside target of 196.26. We should have a stop loss in place at 204.12 though in case the stock begins to move against the trade. By rule, any test of resistance is a short signal. In this case, if resistance, 203.64, is being tested a short signal would exist. Because this plan is a short plan based on a test of resistance it is referred to as a Short Resistance Plan.
MRNA Technical Summary | Raw Data for the Trading Plans
| Term → | Near | Mid | Long |
|---|---|---|---|
| Bias | Strong | Strong | Strong |
| P1 | 0 | 0 | 76.74 |
| P2 | 196.26 | 193.43 | 111.56 |
| P3 | 203.64 | 208.37 | 150.97 |
COMTEX_493520426/2570/2026-09-29T15:08:24